CEO Jensen Huang confirmed that his company has invested in the latest funding round for Elon Musk's generative artificial ...

In our previous article, we rated the shares a buy under $7, which is where they are at the moment, but are they still a buy?

Read here for Boston Scientific (BSX) stock's outlook ahead of Q3 earnings, assess valuation, margin pressures, and ...

ASML Holding (ASML) has appointed Marco Pieters as its new chief technology officer, filling a key leadership vacancy at ...

Target trades at historically low multiples, with downside risks likely priced in, and offers a compelling 5.12% dividend.

Alain Tascan, head of Netflix’s gaming business, said many entertainment companies have failed to enter the video game ...

Solowin Holdings' offshore Cayman Islands structure exposes investors to significant regulatory risks. Read why SWIN stock is ...

US airlines are poised for moderate earnings, with expectations for Q3 2025 looking considerably weaker than Q3 2024. Read ...

Novo Nordisk faces significant threats from compounded and knockoff GLP-1 drugs, impacting its sales and pricing power. See ...

NeoVolta (NEOV) has announced the signing of an asset purchase agreement for Neubau Energy's next-generation modular battery ...

France has been in the news lately for mounting political turmoil marked by Prime Minister Lecornu’s resignation, deepening ...

The London Company portfolios faced headwinds in Q3 as quality factors underperformed and more speculative, high beta stocks ...